Zolbetuximab (development code IMAB362) is an experimental monoclonal antibody against isoform 2 of Claudin-18. It is under investigation for the treatment of gastrointestinal adenocarcinomas and pancreatic tumors.
Zolbetuximab Biosimilar Antibody
$205.00 – $2,500.00
Zolbetuximab is a humanized immunoglobulin (Ig) G1-kappa monoclonal antibody against human Claudin-18.2 protein.
Host/Isotype: Human/IgG1
Class: Monoclonal
Immunogen: Human Claudin-18.2 protein
Production platform: CHO cells
Purification: Affinity chromatography
Storage buffer: PBS, pH 7.2
Storage condition: –20°C
For Research Use Only. Not for use in clinical diagnostics or therapeutics.
Additional information
Antibody Production Scale | 50 ug, 250 ug, 1 mg |
---|---|
Conjugate | None, FITC, HRP, ADC (custom drug) |
You must be logged in to post a review.
Reviews
There are no reviews yet.